{"id":37,"date":"2017-06-01T12:03:59","date_gmt":"2017-06-01T12:03:59","guid":{"rendered":"http:\/\/myklebost.w.uib.no\/?page_id=37"},"modified":"2022-01-27T10:07:37","modified_gmt":"2022-01-27T10:07:37","slug":"sarcoma-team-members","status":"publish","type":"page","link":"https:\/\/myklebost.w.uib.no\/nb\/sarcoma-team-members\/","title":{"rendered":"Myklebost team members"},"content":{"rendered":"<p><span style=\"color: #048778\"><strong>At UiB I have two group members:<\/strong><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-51 alignleft\" src=\"http:\/\/myklebost.w.uib.no\/files\/2017\/06\/80x_c4dfd728416b339b0c3536502ec30e91AnastassiaSmall.jpg\" alt=\"\" width=\"80\" height=\"99\" \/><\/p>\n<p><strong>Anastassia Serguienko<\/strong> is a postdoc employed on a grant from the Research Council, in a collaboration with OncoImmunity to investigate the presence of neoantigens in our NosarC samples, with the aim to identify predictive markers or novel strategies for immune therapy.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-520 alignleft\" style=\"font-weight: bold;color: #707070;font-family: 'Noto Sans', sans-serif;text-align: inherit\" src=\"http:\/\/myklebost.w.uib.no\/files\/2019\/05\/LAMZ-251x300.jpg\" alt=\"\" width=\"82\" height=\"98\" srcset=\"https:\/\/myklebost.w.uib.no\/files\/2019\/05\/LAMZ-251x300.jpg 251w, https:\/\/myklebost.w.uib.no\/files\/2019\/05\/LAMZ.jpg 678w\" sizes=\"auto, (max-width: 82px) 100vw, 82px\" \/><\/p>\n<p><strong>Leonardo A Meza-Zepeda<\/strong> has a 20 % senior scientist position affiliated with the KG Jebsen Centre for Genome-directed Cancer Therapy. He is head of the Section for Core Facilities at OUS &#8211; Radiumhospitalet and an expert on cancer genomics. His project here is the genomics of the NoSarC cohort<\/p>\n<p><strong><span style=\"color: #008080\">In Oslo I have a 3% (!) affiliation with the <a href=\"http:\/\/radium.no\/wesche\">Molecular Biology of sarcomas Group of J\u00f8rgen Wesche<\/a>, where I still have one PhD student.<\/span><\/strong><\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-43 alignleft\" src=\"http:\/\/myklebost.w.uib.no\/files\/2017\/06\/Tatjana-G-150x150.gif\" alt=\"tatjana-g\" width=\"86\" height=\"86\" \/>Tatiana Georgiesh<\/strong> is a PhD student cosupervised by Bodil Bjerkehagen. Her project is &laquo;Investigation of somatic mutations as diagnostic tool, malignancy grade determination and as prognostic factors in soft tissue sarcomas&raquo;, funded by the grant from Krafttak mot Kreft (The Cancer Society) to NoSarC.<span style=\"color: #048778\"><strong>At UiB I have two group members:<\/strong><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-51 alignleft\" src=\"http:\/\/myklebost.w.uib.no\/files\/2017\/06\/80x_c4dfd728416b339b0c3536502ec30e91AnastassiaSmall.jpg\" alt=\"\" width=\"80\" height=\"99\" \/><\/p>\n<p><strong>Anastassia Serguienko<\/strong> is a postdoc employed on a grant from the Research Council, in a collaboration with OncoImmunity to investigate the presence of neoantigens in our NosarC samples, with the aim to identify predictive markers or novel strategies for immune therapy.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-520 alignleft\" style=\"font-weight: bold;color: #707070;font-family: 'Noto Sans', sans-serif;text-align: inherit\" src=\"http:\/\/myklebost.w.uib.no\/files\/2019\/05\/LAMZ-251x300.jpg\" alt=\"\" width=\"82\" height=\"98\" srcset=\"https:\/\/myklebost.w.uib.no\/files\/2019\/05\/LAMZ-251x300.jpg 251w, https:\/\/myklebost.w.uib.no\/files\/2019\/05\/LAMZ.jpg 678w\" sizes=\"auto, (max-width: 82px) 100vw, 82px\" \/><\/p>\n<p><strong>Leonardo A Meza-Zepeda<\/strong> has a 20 % senior scientist position affiliated with the KG Jebsen Centre for Genome-directed Cancer Therapy. He is head of the Section for Core Facilities at OUS &#8211; Radiumhospitalet and an expert on cancer genomics. His project here is the genomics of the NoSarC cohort<\/p>\n<p><strong><span style=\"color: #008080\">In Oslo I have a 3% (!) affiliation with the <a href=\"http:\/\/radium.no\/wesche\">Molecular Biology of sarcomas Group of J\u00f8rgen Wesche<\/a>, where I still have one PhD student.<\/span><\/strong><\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-43 alignleft\" src=\"http:\/\/myklebost.w.uib.no\/files\/2017\/06\/Tatjana-G-150x150.gif\" alt=\"tatjana-g\" width=\"86\" height=\"86\" \/>Tatiana Georgiesh<\/strong> is a PhD student cosupervised by Bodil Bjerkehagen. Her project is &laquo;Investigation of somatic mutations as diagnostic tool, malignancy grade determination and as prognostic factors in soft tissue sarcomas&raquo;, funded by the grant from Krafttak mot Kreft (The Cancer Society) to NoSarC.<\/p>","protected":false},"excerpt":{"rendered":"<p>At UiB I have two group members: Anastassia Serguienko is a postdoc employed on a grant from the Research Council, in a collaboration with OncoImmunity to investigate the presence of neoantigens in our NosarC samples, with the aim to identify predictive markers or novel strategies for immune therapy. Leonardo A Meza-Zepeda has a 20 % &hellip; <a href=\"https:\/\/myklebost.w.uib.no\/nb\/sarcoma-team-members\/\" class=\"more-link\">Fortsett \u00e5 lese <span class=\"screen-reader-text\">Myklebost team members<\/span><\/a><\/p>\n","protected":false},"author":3681,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-37","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/pages\/37","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/users\/3681"}],"replies":[{"embeddable":true,"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/comments?post=37"}],"version-history":[{"count":49,"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/pages\/37\/revisions"}],"predecessor-version":[{"id":712,"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/pages\/37\/revisions\/712"}],"wp:attachment":[{"href":"https:\/\/myklebost.w.uib.no\/nb\/wp-json\/wp\/v2\/media?parent=37"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}